Top

International Urology and Nephrology

Published in:

01-09-2014 | Urology - Original Paper

The value of respective urodynamic parameters for evaluating the occurrence of complications linked to benign prostatic enlargement

Authors: Xingliang Yang, Kai Wang, Jiang Zhao, Wei Yu, Longkun Li

Published in: International Urology and Nephrology | Issue 9/2014

Abstract

Purpose

To assess the correlation between urodynamic parameters and urinary tract complications linked to benign prostatic enlargement (BPE), as well to assess the possible value of these parameters for predicting complications.

Methods

We retrospectively analyzed the relationship between the complications and correlative urodynamic data of 486 BPH patients. Multivariate stepwise logistic regression was used to identify major independent predictors and establish regression models. Receiver operating characteristic (ROC) curves were constructed to evaluate the models’ predictive values.

Results

All of the individual parameters examined significantly correlated with most of the complications linked to BPE, except bladder calculus. According to ROC analysis, all of the areas under ROC curves (AUC), comparison of the individual parameters and the combined effects from the logistical regression models reached statistical significance (p < 0.05), and combining the parameters revealed a higher AUC compared to the individual parameters; however, all of the AUCs were below 0.9.

Conclusions

Urodynamic parameters are significantly correlated with most of the complications linked to BPE, and these parameters have predictive value for the occurrence of these complications with limited values.

Priest R, Garzotto M, Kaufman J (2012) Benign prostatic hyperplasia: a brief overview of pathogenesis, diagnosis, and therapy. Tech Vasc Interv Radiol 15(4):261–264PubMedCrossRef

Bushman W (2009) Etiology, epidemiology, and natural history of benign prostatic hyperplasia. Urol Clin North Am 36(4):403–415PubMedCrossRef

Gray M (2010) Traces: making sense of urodynamics testing–part 2: uroflowmetry. Urol Nurs 30(6):321–326PubMed

Oelke M, Kirschner-Hermanns R, Thiruchelvam N, Heesakkers J (2012) Can we identify men who will have complications from benign prostatic obstruction (BPO)? ICI-RS 2011. Neurourol Urodyn 31(3):322–326PubMedCrossRef

Parsons BA, Hashim H (2011) Emerging treatment options for benign prostatic obstruction. Curr Urol Rep 12(4):247–254PubMedCrossRef

Reilly NJ (1994) The release of the clinical practice guideline: benign prostatic hyperplasia: diagnosis and treatment. Urol Nurs 14(2):37PubMed

McConnell JD, Roehrborn CG, Bautista OM et al (2003) The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 349:2387–2398PubMedCrossRef

Nitti VW (2005) Pressure flow urodynamic studies: the gold standard for diagnosing bladder outlet obstruction. Rev Urol 7(Suppl 6):S14–S21PubMedCentralPubMed

Abrams P (1999) Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function. BJU Int 84(1):14–15PubMedCrossRef

10.

Jacobsen SJ, Jacobson DJ, Girman CJ, Roberts RO, Rhodes T, Guess HA, Liebe MM (1997) Natural history of prostatism: risk factors for acute urinary retention. J Urol 158(2):481–487PubMedCrossRef

11.

Crawford ED, Wilson SS, McConnell JD et al (2006) Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo. J Urol 175(4):1422–1426; discussion 1426–7

12.

Ko YH, Chae JY, Jeong SM, Kang JI, Ahn HJ, Kim HW, Kang SG, Jang HA, Cheon J, Kim JJ, Lee JG (2010) Clinical implications of residual urine in Korean benign prostatic hyperplasia (BPH) patients: a prognostic factor for BPH-related clinical events. Int Neurourol J 14(4):238–244PubMedCentralPubMedCrossRef

13.

Millan-Rodriguez F, Errando-Smet C, Rousaud-Baron F et al (2004) Urodynamic findings before and after noninvasive management of bladder calculi. BJU Int 93:1267–1270PubMedCrossRef

14.

Madersbacher S, Alivizatos G, Nordling J et al (2004) EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol 46:547–554PubMedCrossRef

15.

Taylor JA 3rd, Kuchel GA (2006) Detrusor underactivity: clinical features and pathogenesis of an under diagnosed geriatric condition. J Am Geriatr Soc 54(12):1920–1932PubMedCrossRef

16.

Guo LJ, Tang Y, Guo CM, Zhang XH (2010) Impact of primary hypertension on hematuria of the patients with benign prostatic hyperplasia. Chin Med J (Engl) 123(9):1154–1157

17.

Hochberg DA, Basillote JB, Armenakas NA, Vasovic L, Shevchuk M, Pareek G, Fracchia JA (2002) Decreased suburethral prostatic microvessel density in finasteride treated prostates: a possible mechanism for reduced bleeding in benign prostatic hyperplasia. J Urol 167(4):1731–1733PubMedCrossRef

18.

Stachon A, Aweimer A, Stachon T, Tannapfel A, Thoms S, Ubrig B, Köller M, Krieg M, Truss MC (2009) Secretion of soluble VEGF receptor 2 by microvascular endothelial cells derived by human benign prostatic hyperplasia. Growth Factors 27(2):71–78PubMedCrossRef

19.

Childs MA, Mynderse LA, Rangel LJ, Wilson TM, Lingeman JE, Krambeck AE (2013) Pathogenesis of bladder calculi in the presence of urinary stasis. J Urol 189(4):1347–1351PubMedCentralPubMedCrossRef

20.

Belal M, Abrams P (2006) Noninvasive methods of diagnosing bladder outlet obstruction in men. Part 1: nonurodynamic approach. J Urol 176:22–28PubMedCrossRef

21.

Arnolds ML, Oelke M (2009) Positioning invasive versus noninvasive urodynamics in the assessment of bladder outlet obstruction. Curr Opin Urol 19:55–62PubMedCrossRef

22.

Oelke M (2010) International Consultation on Incontinence-Research Society (ICI-RS) report on non-invasive urodynamics: the need of standardization of ultrasound bladder and detrusor wall thickness measurements to quantify bladder wall hypertrophy. Neurourol Urodyn 29:634–639PubMedCrossRef

23.

Chia SJ, Heng CT, Chan SP et al (2003) Correlation of intravesical prostatic protrusion with bladder outlet obstruction. BJU Int 91:371–374PubMedCrossRef

24.

Miyashita H, Kojima M, Miki T (2002) Ultrasonic measurement of bladder weight as a possible predictor of acute urinary retention in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Ultrasound Med Biol 28:985–990PubMedCrossRef

Title: The value of respective urodynamic parameters for evaluating the occurrence of complications linked to benign prostatic enlargement
Authors: Xingliang Yang
Kai Wang
Jiang Zhao
Wei Yu
Longkun Li
Publication date: 01-09-2014
Publisher: Springer Netherlands
Published in: International Urology and Nephrology / Issue 9/2014
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI: https://doi.org/10.1007/s11255-014-0722-1

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 9/2014

End-stage renal disease in tuberous sclerosis complex-polycystic kidney disease contiguous gene syndrome: epidemiology, clinical manifestations and implications for transplantation

Aspirin use and the risk of prostate cancer: a meta-analysis of 24 epidemiologic studies

Plication corporoplasty for congenital penile curvature: our results with long-term follow-up

Multiple hypoplastic duplicated urethral hydrodistension and simple end-to-end anastomosis to penoscrotal hypospadias: a novel technique

Insertion technique for prevention of peritoneal dialysis catheter tip migration

Role of the VEGF 936 gene polymorphism and VEGF-A levels in the late-term arteriovenous fistula thrombosis in patients undergoing hemodialysis

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials